
Brand Name | Status | Last Update |
|---|---|---|
| tavos hand sanitizer gel | OTC monograph not final | 2022-02-22 |
| tavos liquid hand sanitizer | OTC monograph not final | 2021-08-27 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | — | 1 | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | — | 1 | — | — | — | 1 |
| Drug common name | TAVOKINOGENE TELSEPLASMID |
| INN | tavokinogene telseplasmid |
| Description | Tavokinogene telseplasmid is a gene pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Gene |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4298206 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | MF4P7VQ2K8 (ChemIDplus, GSRS) |

